
Greg Steube Periodic Transaction Report
Filed Mar 15, 2024 · House Clerk · 1 transaction
U.S. Representative · R · FL-17 · All trades by Greg Steube
On March 15, 2024, Rep. Greg Steube (R-FL-17) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated Feb 16, 2024.
The filing covers 1 ticker, including $SNV.
Reported amount ranges sum to $15K–$50K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 28 days.
1 transaction was reported under a spouse, dependent child, or joint account rather than the member directly.
Source document: House Clerk filing 20024660
Sample · the intelligence layer
Greg Steube · Bought $SNV · Feb 16 · $15K–$50K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Greg Steube
Get an email the moment Greg Steube files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Feb 16, 2024 | SNVSNVSynovus Financial Corp. Common Stock | Synovus Financial Corp. Common Stock (SNV) | buy | Spouse | $15K–$50K | 28d |
The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.
Other recent filings by Greg Steube
- PTR filed Apr 14, 20262 trades · IONQ
- PTR filed Jul 16, 20251 trade
- PTR filed Apr 4, 20251 trade · SNV
- PTR filed Apr 6, 20241 trade · SNV
- PTR filed Aug 9, 20231 trade · SNV
- PTR filed Mar 15, 20232 trades · SNV
← All congressional filings, newest firstFiled Mar 15, 2024March 2024 archive
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →